These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7107976)

  • 61. A comparative 25-night sleep laboratory study on the effects of quazepam and triazolam on chronic insomniacs.
    Mamelak M; Csima A; Price V
    J Clin Pharmacol; 1984; 24(2-3):65-75. PubMed ID: 6143767
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Model insomnia, noise, and methylphenidate, used for the evaluation of hypnotic drugs.
    Okuma T; Honda H
    Psychopharmacology (Berl); 1978 Apr; 57(2):127-32. PubMed ID: 206923
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characteristics of chronic insomniacs examined in a multicenter 14-day study of flurazepam and midazolam.
    Roth T; Roehrs T; Linnoila M; Judd LL
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):24S-27S. PubMed ID: 2229459
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sensitivity of cyclic alternating pattern to prolonged pharmacotherapy: a 5-week study evaluating zolpidem in insomniac patients.
    Terzano MG; Parrino L; Boselli M; Spaggiari MC; Di Giovanni G; Smerieri A
    Clin Neuropharmacol; 1997 Oct; 20(5):447-54. PubMed ID: 9331522
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of flurazepam and zolpidem on the perception of sleep in normal volunteers.
    Mendelson WB
    Sleep; 1995 Feb; 18(2):88-91. PubMed ID: 7792497
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: an introduction.
    Johnson LC; Chernik DA; Sateia MJ
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):5S-9S. PubMed ID: 2121802
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Traffic noise-induced sleep disturbances and their correction by an anxiolytic sedative, OX-373.
    Saletu B; Grünberger J
    Neuropsychobiology; 1981; 7(6):302-14. PubMed ID: 6118840
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sleep laboratory study of the effects of midazolam in insomniac patients.
    Monti JM; Debellis J; Gratadoux E; Alterwain P; Altier H; D'Angelo L
    Eur J Clin Pharmacol; 1982; 21(6):479-84. PubMed ID: 7075654
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T; Soubrane C; Titeux L; Walsh JK;
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of flurazepam on sleep, arousal threshold, and the perception of being asleep.
    Mendelson WB; Martin JV; Stephens H; Giesen H; James SP
    Psychopharmacology (Berl); 1988; 95(2):258-62. PubMed ID: 3137607
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of alcohol on polysomnographically recorded sleep in healthy subjects.
    Feige B; Gann H; Brueck R; Hornyak M; Litsch S; Hohagen F; Riemann D
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1527-37. PubMed ID: 16930215
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of a single dose of flurazepam on the sleep of healthy volunteers.
    Ancoli-Israel S; Kripke DF; Zorick F; Roth T
    Arzneimittelforschung; 1984; 34(1):99-100. PubMed ID: 6538429
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A comparison of temazepam and flurazepam in terms of sleep quality and residual changes in performance.
    Wesnes K; Warburton DM
    Neuropsychobiology; 1984; 11(4):255-9. PubMed ID: 6149491
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sleep laboratory investigations on hypnotic properties of melatonin.
    Waldhauser F; Saletu B; Trinchard-Lugan I
    Psychopharmacology (Berl); 1990; 100(2):222-6. PubMed ID: 2305009
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chronic benzodiazepine usage and withdrawal in insomnia patients.
    Poyares D; Guilleminault C; Ohayon MM; Tufik S
    J Psychiatr Res; 2004; 38(3):327-34. PubMed ID: 15003439
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy and side effects of flurazepam and a combination of amobarbital and secobarbital in insomniac patients.
    Linnoila M; Erwin CW; Logue PE
    J Clin Pharmacol; 1980; 20(2-3):117-23. PubMed ID: 6991532
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long-term hypnotic efficacy and safety of triazolam and flurazepam.
    Leibowitz M; Sunshine A
    J Clin Pharmacol; 1978; 18(5-6):302-9. PubMed ID: 25288
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise.
    Saletu B; Kindshofer G; Anderer P; Grünberger J
    Int J Clin Pharmacol Res; 1987; 7(5):407-18. PubMed ID: 2889679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.